NEWS AND RESOURCES

Content Type: News Events Webinars Resources Publications Blogs Promotion

RESEARCH AREA: Metabolism Cardioangiology Oncology Immunology Neurology Infectious Disease Cell and Gene Therapy Rare Disease Other

FEATURED PROJECTS

April 10, 2024

Share

AACR 2024 Poster Resources

Our scientists, proudly presented 7 scientific posters at AACR 2024. You can download poster presentations covering a variety of research topics.

LEARN MORE
March 11, 2024

Share

AACR Annual Meeting 2024

GemPharmatech will be exhibiting at this year’s American Association for Cancer Research’s annual meeting!
Bookmark this event page to stay up to date on our booth information, scientific posters, and giveaways.

LEARN MORE
April 03, 2024

Share

Modeling Autoimmune Diseases Utilizing Mice with Humanized Immune Systems

LEARN MORE

ALL POSTS

Resources

April 10, 2024

AACR 2024 Poster Resources

Our scientists, proudly presented 7 scientific posters at AACR 2024. You can download poster presentations covering a variety of research topics.
Resources

March 07, 2024

Whisker Wisdom: Efficient Blood Glucose Testing Procedures for BKS-db Mice
Resources

February 29, 2024

GemPharmatech takes you to understand the rare disease - Mucopolysaccharidosis
Resources

February 29, 2024

Rare Disease Day 2024: Models to Effect Change
Resources

February 20, 2024

2024 brings great news! The fourth high-quality article on the FAD4T Alzheimer's disease mouse model, developed independently by GemPharmatech, has been published!
Resources

February 20, 2024

Another high-quality article published using Alzheimer’s disease mouse model FAD4T from GemPharmatech
Resources

January 19, 2024

ADA 2023 Poster Resources
Resources

July 01, 2023

GPT’s Fully-human antibody transgenic mouse, NeoMab™
News

September 13, 2023

GemPharmatech's Board Appoints Brandy Wilkinson, Ph.D. as its New Chief Executive Officer of GemPharmatech LLC.

GemPharmatech LLC., a leading contract research organization, announced today that its Board of Directors has appointed Dr. Brandy Wilkinson as the Chief Executive Officer of its subsidiary in the United States, effective September 12, 2023.

LEARN MORE